Scholarlink

<p>Immune checkpoint blockades (ICBs) have potential application in cancer therapy. The lack of adaptive resistance and immunogenicity in cells substantially restricts their preclinical efficiency. Immunogenic cell death (ICD), a form of regulated cell death, plays a crucial role in activating the adaptive immune response. A co-assembled metal coordination nanocomposite (PIF NCs) that improves cancer immunotherapy by promoting ICD via ferroptosis-photochemotherapy induction is developed. The PIF NCs demonstrated exceptional stability and biocompatibility and exhibited effective photodynamic therapy and photothermal therapy effects. PIF NCs disrupt the redox equilibrium and trigger ferroptosis by depleting glutathione (GSH), downregulating glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11), and increasing the production of lipid peroxides (LPO). PIF NCs initiate the ICD cascade, thereby augmenting tumor immunogenicity. In a Hep3B tumor model, combined treatment with PIF NCs and anti-PD-L1 exhibited substantial inhibitory efficacy and induced a prolonged immunological memory response. This synergistic treatment of multimodal therapy can potentially be used in the treatment of hepatocellular carcinoma.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Supramolecular co-assembly of platycodin-d-loaded iron nanocomposite enhances hepatocellular carcinoma immunotherapy with synergistic ferroptosis–photo-chemotherapy

  • 期刊论文

  • 发表日期：

    2026年5月14日

查看全文
  • Kai Yang,
  • E Ke,
  • Qin Zhang,
  • Jing Chen,
  • Miao Tian,
  • Jing Wang,
  • Guoxing Zhang,
  • Hai Zhang

摘要

Immune checkpoint blockades (ICBs) have potential application in cancer therapy. The lack of adaptive resistance and immunogenicity in cells substantially restricts their preclinical efficiency. Immunogenic cell death (ICD), a form of regulated cell death, plays a crucial role in activating the adaptive immune response. A co-assembled metal coordination nanocomposite (PIF NCs) that improves cancer immunotherapy by promoting ICD via ferroptosis-photochemotherapy induction is developed. The PIF NCs demonstrated exceptional stability and biocompatibility and exhibited effective photodynamic therapy and photothermal therapy effects. PIF NCs disrupt the redox equilibrium and trigger ferroptosis by depleting glutathione (GSH), downregulating glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11), and increasing the production of lipid peroxides (LPO). PIF NCs initiate the ICD cascade, thereby augmenting tumor immunogenicity. In a Hep3B tumor model, combined treatment with PIF NCs and anti-PD-L1 exhibited substantial inhibitory efficacy and induced a prolonged immunological memory response. This synergistic treatment of multimodal therapy can potentially be used in the treatment of hepatocellular carcinoma.

Graphical abstract